GABA as an Overlooked Mediator of Metformin Action: GABA-mediated Neuropsychiatric and Hepatoprotective Activities of Metformin
Abstract
Background: According to treatment guidelines, metformin is the first-line medication for type 2 diabetes. The neuropsychiatric and hepatoprotective activities of metformin, mediated by modulation of gamma-aminobutyric acid (GABA) signalling pathways, have recently attracted the attention of researchers.
Summary: The objective of this narrative review is to compile the most recent data from original research on the GABA-mediated effects of metformin in a range of disorders. Original articles were searched from various electronic databases using relevant search terms. According to animal studies on rodent models of anxiety, metformin increases the intracellular level of AMP-activated protein kinase and GABAergic neurotransmission in the hippocampus and medial prefrontal cortex, resulting in anxiolytic effects. Similarly, metformin increased the levels of GABA and lowered the levels of glutamate in the hippocampus of diabetic epileptic rats. This action was associated with reduced neuroinflammation and apoptosis and improved cognitive function and seizure outcomes. Additionally, an open-label clinical trial with people who have Fragile X syndrome demonstrated that metformin is potentially an effective treatment, and it might improve GABA-mediated inhibition of the cortex as a mechanism. Moreover, beyond the neuropsychiatric action in the central nervous system, metformin reduced ferroptosis in a mouse model of hepatic ischemia/reperfusion injury, with GABA identified as a key…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.